FAT1 and acute lymphoblastic leukemia: The observation of cell proliferation over a prolonged time period of 10 days led to enriched counts for FAT1high Jurkat T-ALL cells further underlining the proliferative advantage of high FAT1 expression as shown by WST proliferation assays shown (Fig. 4a; d–f).